{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:27:01Z","timestamp":1753889221899,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T00:00:00Z","timestamp":1520640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"French Ministry of Health","award":["PHRC 2002"],"award-info":[{"award-number":["PHRC 2002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10549-018-4733-y","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T11:44:12Z","timestamp":1520682252000},"page":"303-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial"],"prefix":"10.1007","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-3198","authenticated-orcid":false,"given":"P.","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leizorovicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Villet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Y.","family":"Bobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,10]]},"reference":[{"key":"4733_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/bjc.1992.230","volume":"66","author":"D Ivens","year":"1992","unstructured":"Ivens D, Hoe AL, Podd TJ et al (1992) Assessment of morbidities from complete axillary dissection. Br J Cancer 66:136\u2013138","journal-title":"Br J Cancer"},{"key":"4733_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0959-8049(96)00375-9","volume":"33","author":"G Liljegren","year":"1997","unstructured":"Liljegren G, Holomberg L, The Uppsala Orebro Breast Study Group (1997) Arm morbidity after sector resection and axillary dissection with and without radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 33:193\u2013199","journal-title":"Eur J Cancer"},{"key":"4733_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/(SICI)1097-0142(20000415)88:8<1852::AID-CNCR14>3.0.CO;2-L","volume":"88","author":"JS Jackson","year":"2000","unstructured":"Jackson JS, Olivotto IA, Wai EMDE et al (2000) A decision analysis of the effect of avoiding axillary lymph node dissection in low risk women with invasive breast carcinoma. Cancer 88:1852\u20131862","journal-title":"Cancer"},{"key":"4733_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391\u2013398","journal-title":"Ann Surg"},{"key":"4733_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"4733_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J R Stat Soc Ser B Stat Methodol 34:187\u2013220","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"4733_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#","volume":"18","author":"PK Andersen","year":"1999","unstructured":"Andersen PK, Klein JP, Zhang MJ (1999) Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 18:1489\u20131500","journal-title":"Stat Med"},{"key":"4733_CR8","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","volume":"251","author":"U Veronesi","year":"2010","unstructured":"Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251:595\u2013600","journal-title":"Ann Surg"},{"key":"4733_CR9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927\u2013933","journal-title":"Lancet Oncol"},{"key":"4733_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599\u2013609","journal-title":"J Natl Cancer Inst"},{"key":"4733_CR11","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881\u2013888","journal-title":"Lancet Oncol"},{"key":"4733_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa012782","volume":"349","author":"U Veronesi","year":"2003","unstructured":"Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546\u2013553","journal-title":"N Engl J Med"},{"key":"4733_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1023\/A:1026743914286","volume":"11","author":"P Roy","year":"2000","unstructured":"Roy P, Est\u00e8ve J, Bobin JY (2000) Methodological questions in sentinel lymph node analysis in breast cancer patients. Ann Oncol 11:1381\u20131385","journal-title":"Ann Oncol"},{"key":"4733_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cncr.21568","volume":"106","author":"T Kim","year":"2006","unstructured":"Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel node biopsy in early stage breast carcinoma. Cancer 106:4\u201316","journal-title":"Cancer"},{"key":"4733_CR15","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1200\/JCO.2010.28.2491","volume":"28","author":"SR Land","year":"2010","unstructured":"Land SR, Kopec JA, Julian TB et al (2010) Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillar dissection: national surgical adjuvant breast and bowel project phase III protocol B-32. J Clin Oncol 28:3929\u20133936","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-018-4733-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-018-4733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T22:52:24Z","timestamp":1719874344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-018-4733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4733"],"URL":"https:\/\/doi.org\/10.1007\/s10549-018-4733-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2018,3,10]]},"assertion":[{"value":"20 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Trial GF-GS01 was carried out after approval from local institutional review boards and in accordance with assurances filed with and approved by the French Minist\u00e8re de la Sant\u00e9 et des Affaires Sociales. Informed consent was obtained from all individual participants included in the study. The trial is registered under number (NCT00144898) in clinical.trial.gov and number RECF0322 in the database of the French Institut National du Cancer. The investigators obtained informed consent from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}}]}}